PL2340033T3 - Preparat zawierający insulinę, nikotynamid i argininę - Google Patents

Preparat zawierający insulinę, nikotynamid i argininę

Info

Publication number: PL2340033T3
Authority: PL; Poland
Prior art keywords: nicotinamide; insulin; arginine; preparation
Prior art date: 2009-06-26

Application number

PL10730134T

Other languages

English (en)

Inventor

Helle Birk Olsen

Svend Havelund

Ulla Ribel

Jeppe Sturis

Helle Naver

Morten Schlein

Svend Ludvigsen

Original Assignee

Novo Nordisk As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-06-26

Filing date

2010-06-25

Publication date

2014-03-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41351568&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2340033(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2010-06-25 Application filed by Novo Nordisk As filed Critical Novo Nordisk As

2014-03-31 Publication of PL2340033T3 publication Critical patent/PL2340033T3/pl

Links

DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 title 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title 2
239000004475 Arginine Substances 0.000 title 1
102000004877 Insulin Human genes 0.000 title 1
108090001061 Insulin Proteins 0.000 title 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 title 1
229940125396 insulin Drugs 0.000 title 1
229960003966 nicotinamide Drugs 0.000 title 1
235000005152 nicotinamide Nutrition 0.000 title 1
239000011570 nicotinamide Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Oil, Petroleum & Natural Gas (AREA)
Endocrinology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Dermatology (AREA)
Inorganic Chemistry (AREA)
Hematology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)

PL10730134T 2009-06-26 2010-06-25 Preparat zawierający insulinę, nikotynamid i argininę PL2340033T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
EP09163940		2009-06-26
US22216809P	2009-07-01	2009-07-01
EP10730134.3A EP2340033B1 (en)	2009-06-26	2010-06-25	PREPARATION COMPRISING INSULIN, NICOTINAMIDE AND Arginine
PCT/EP2010/059069 WO2010149772A1 (en)	2009-06-26	2010-06-25	Preparation comprising insulin, nicotinamide and an amino acid

Publications (1)

Publication Number	Publication Date
PL2340033T3 true PL2340033T3 (pl)	2014-03-31

Family

ID=41351568

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL10730134T PL2340033T3 (pl)	2009-06-26	2010-06-25	Preparat zawierający insulinę, nikotynamid i argininę
PL13158960T PL2612677T3 (pl)	2009-06-26	2010-06-25	Preparat zawierający insulinę, nikotynamid i argininę

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
PL13158960T PL2612677T3 (pl)	2009-06-26	2010-06-25	Preparat zawierający insulinę, nikotynamid i argininę

Country Status (20)

Country	Link
US (4)	US8324157B2 (pl)
EP (2)	EP2612677B1 (pl)
JP (2)	JP5669834B2 (pl)
KR (1)	KR101775000B1 (pl)
CN (2)	CN104667264B (pl)
AU (1)	AU2010264636B2 (pl)
BR (1)	BRPI1014760B8 (pl)
CA (1)	CA2764423A1 (pl)
DK (2)	DK2612677T3 (pl)
ES (2)	ES2543705T3 (pl)
HU (2)	HUE027239T2 (pl)
IL (1)	IL216520A (pl)
MX (1)	MX2011012764A (pl)
NO (1)	NO2017031I1 (pl)
PL (2)	PL2340033T3 (pl)
PT (2)	PT2612677E (pl)
RU (1)	RU2533217C3 (pl)
TW (1)	TWI459962B (pl)
WO (1)	WO2010149772A1 (pl)
ZA (1)	ZA201108942B (pl)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9060927B2 (en)	2009-03-03	2015-06-23	Biodel Inc.	Insulin formulations for rapid uptake
US9018190B2 (en)	2009-03-27	2015-04-28	Adocia	Functionalized oligosaccharides
FR2943538B1 (fr)	2009-03-27	2011-05-20	Adocia	Formulation a action rapide d'insuline recombinante humaine
HUE027239T2 (en) *	2009-06-26	2016-10-28	Novo Nordisk As	Preparation containing insulin, nicotinamide and arginine
CA2821613A1 (en) *	2010-12-14	2012-06-21	Novo Nordisk A/S	Preparation comprising insulin, nicotinamide and an amino acid
US20130011378A1 (en)	2011-06-17	2013-01-10	Tzung-Horng Yang	Stable formulations of a hyaluronan-degrading enzyme
GB201113880D0 (en) *	2011-08-12	2011-09-28	Archimed Llp	Novel compositions
US20130231281A1 (en)	2011-11-02	2013-09-05	Adocia	Rapid acting insulin formulation comprising an oligosaccharide
BR112014016195A2 (pt)	2011-12-30	2020-10-27	Halozyme, Inc.	variantes de polipeptídio ph20, formulações e usos das mesmas
WO2013186138A1 (en) *	2012-06-14	2013-12-19	Novo Nordisk A/S	Preparation comprising insulin, nicotinamide and arginine
WO2014076423A1 (fr)	2012-11-13	2014-05-22	Adocia	Formulation à action rapide d'insuline comprenant un composé anionique substitué
RU2015129087A (ru)	2012-12-19	2017-02-02	Вокхардт Лимитед	Стабильная водная композиция, содержащая инсулин человека или его аналог или производное
RU2019128331A (ru) *	2013-02-04	2019-12-16	Санофи	Стабилизированные фармацевтические составы аналогов инсулина и/или производные инсулина
TWI641381B (zh) *	2013-02-04	2018-11-21	法商賽諾菲公司	胰島素類似物及／或胰島素衍生物之穩定化醫藥調配物
TW201534726A (zh)	2013-07-03	2015-09-16	Halozyme Inc	熱穩定ｐｈ２０玻尿酸酶變異體及其用途
EP3091995B1 (en)	2014-01-09	2024-03-20	Sanofi	Stabilized pharmaceutical formulations of insulin aspart
US20150273022A1 (en) *	2014-02-10	2015-10-01	Biodel Inc.	Stabilized ultra-rapid-acting insulin formulations
US20170028031A1 (en) *	2014-03-07	2017-02-02	Klavs Holger Jørgensen	Novel fast acting insulin preparations
JO3624B1 (ar)	2014-05-08	2020-08-27	Lilly Co Eli	تركيبات إنسولين سريعة المفعول
US9795678B2 (en)	2014-05-14	2017-10-24	Adocia	Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound
FR3020947B1 (fr)	2014-05-14	2018-08-31	Adocia	Composition aqueuse comprenant au moins une proteine et un agent solubilisant, sa preparation et ses utilisations
AR102869A1 (es)	2014-12-16	2017-03-29	Lilly Co Eli	Composiciones de insulina de rápida acción
ES2972423T3 (es)	2015-07-28	2024-06-12	Lilly Co Eli	Preparado farmacéutico para mejorar la absorción y la acción hipoglucemiante postprandial de la insulina
JO3749B1 (ar)	2015-08-27	2021-01-31	Lilly Co Eli	تركيبات إنسولين سريعة المفعول
FR3043557B1 (fr)	2015-11-16	2019-05-31	Adocia	Composition a action rapide d'insuline comprenant un citrate substitue
GB201607918D0 (en)	2016-05-06	2016-06-22	Arecor Ltd	Novel formulations
GB201613895D0 (en)	2016-08-12	2016-09-28	Arecor Ltd	Novel composition
US20190282667A1 (en)	2016-09-29	2019-09-19	Arecor Limited	Novel formulations
GB201707189D0 (en)	2017-05-05	2017-06-21	Arecor Ltd	Novel formulations
GB201707187D0 (en)	2017-05-05	2017-06-21	Arecor Ltd	Novel formulations
GB201707188D0 (en)	2017-05-05	2017-06-21	Arecor Ltd	Novel formulations
US20210113763A1 (en)	2018-04-04	2021-04-22	Arecor Limited	Medical infusion pump system for the delivery of an insulin compound
CA3094237A1 (en)	2018-04-04	2019-10-10	Arecor Limited	Medical infusion pump system for the delivery of an insulin compound
JP7465813B2 (ja)	2018-04-04	2024-04-11	アレコルリミテッド	インスリン化合物の送達のための医療用注入ポンプシステム
WO2019243627A1 (fr)	2018-06-23	2019-12-26	Adocia	Dispositif pour injecter une solution d'insuline(s)
FR3083985A1 (fr)	2018-07-23	2020-01-24	Adocia	Dispositif pour injecter une solution d'insuline(s)
FR3083984A1 (fr)	2018-07-23	2020-01-24	Adocia	Dispositif pour injecter une solution d'insuline(s)
AU2019344541B2 (en)	2018-09-18	2022-01-06	Eli Lilly And Company	Erbumine salt of treprostinil
GB202004814D0 (en)	2020-04-01	2020-05-13	Arecor Ltd	Novel formulations
AR131148A1 (es)	2022-11-26	2025-02-19	Obshchestvo S Ogranichennoy Otvetstvennostyu «Geropharm»	Composiciones de insulina de acción rápida (variantes de las mismas)
WO2024123214A1 (ru)	2022-12-04	2024-06-13	Общество С Ограниченной Ответственностью "Герофарм"	Композиция инсулина аспарта (варианты)
WO2025103501A1 (en) *	2023-11-17	2025-05-22	Wuxi Biologics (Shanghai) Co., Ltd.	Viscosity-reducing and stabilizing liquid formulations for high concentration protein formulations

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4205126A (en) *	1978-01-01	1980-05-27	Cartaya Oscar A	Serum-free cell culture media
NZ199391A (en)	1981-01-02	1985-12-13	Genentech Inc	Chimeric polypeptides comprising a proinsulin sequence,and preparation by recombinant dna technique;production of human insulin
ZA827928B (en) *	1981-10-30	1983-08-31	Novo Industri As	Stabilized insulin preparations and process for preparation thereof
DE3313386A1 (de) *	1983-04-13	1984-10-18	Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., 8000 München	Verfahren zur herstellung von nicht-brennbaren, thermisch isolierenden formkoerpern aus geblaehtem perlit
DK58285D0 (da)	1984-05-30	1985-02-08	Novo Industri As	Peptider samt fremstilling og anvendelse deraf
DK336188D0 (da)	1988-06-20	1988-06-20	Nordisk Gentofte	Propeptider
DK105489D0 (da)	1989-03-03	1989-03-03	Novo Nordisk As	Polypeptid
ES2072596T3 (es) *	1989-12-21	1995-07-16	Novo Nordisk As	Preparaciones de insulina que contienen acido nicotinico o nicotinamida.
AU1272295A (en)	1993-12-17	1995-07-03	Novo Nordisk A/S	Proinsulin-like compounds
RU2175556C2 (ru) *	1994-03-07	2001-11-10	Инхейл Терапьютик Системз	Способы и композиции для легочной доставки инсулина
US6500645B1 (en)	1994-06-17	2002-12-31	Novo Nordisk A/S	N-terminally extended proteins expressed in yeast
ZA954983B (en)	1994-06-17	1996-02-14	Novo Nordisk As	N-terminally extended proteins expressed in yeast
AU3562195A (en)	1994-10-04	1996-04-26	Novo Nordisk A/S	Preparations containing aspb28 human insulin and nicotinamide
KR0150565B1 (ko)	1995-02-15	1998-08-17	김정재	유전자 조환에 의한 사람 인슐린 전구체의 제조 및 이를 이용한 인슐린의 제조방법
AU5724996A (en)	1995-05-05	1996-11-21	Eli Lilly And Company	Single chain insulin with high bioactivity
US6043092A (en) *	1996-03-18	2000-03-28	University Of Pittsburgh	Cell culture media for mammalian cells
US5866538A (en)	1996-06-20	1999-02-02	Novo Nordisk A/S	Insulin preparations containing NaCl
AR012894A1 (es) *	1997-06-13	2000-11-22	Lilly Co Eli	Formulacion de insulina en solucion estable, su uso para preparar un medicamento y proceso para la preparacion de la misma.
SI0884053T1 (en) *	1997-06-13	2003-02-28	Eli Lilly And Company	Stable insulin formulations
WO2001052937A1 (en) *	2000-01-24	2001-07-26	Medtronic Minimed, Inc.	Mixed buffer system for stabilizing polypeptide formulations
US6573237B2 (en)	2001-03-16	2003-06-03	Eli Lilly And Company	Protein formulations
DE10114178A1 (de) *	2001-03-23	2002-10-10	Aventis Pharma Gmbh	Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
CN1635900A (zh) *	2001-08-28	2005-07-06	伊莱利利公司	Glp－1和基础胰岛素的预混合物
US7115563B2 (en)	2002-05-29	2006-10-03	Insignion Holding Limited	Composition and its therapeutic use
US20050232974A1 (en)	2004-04-19	2005-10-20	Gore Makarand P	System and a method for pharmaceutical dosage preparation using jettable microemulsions
AU2007238114B2 (en)	2006-04-12	2010-10-14	Biodel, Inc.	Rapid acting and long acting insulin combination formulations
ES2601839T3 (es)	2006-09-22	2017-02-16	Novo Nordisk A/S	Análogos de insulina resistentes a proteasas
ES2464282T3 (es)	2006-09-27	2014-06-02	Novo Nordisk A/S	Método para preparar polipéptidos de insulina madura
EP2117596B1 (en)	2006-12-15	2018-01-03	TIMA Foundation	Antioxidant composition and its use in diabetes
CN101778862B (zh) *	2007-08-13	2014-12-17	诺沃-诺迪斯克有限公司	快速作用的胰岛素类似物
HUE027239T2 (en) *	2009-06-26	2016-10-28	Novo Nordisk As	Preparation containing insulin, nicotinamide and arginine

2010
- 2010-06-25 HU HUE13158960A patent/HUE027239T2/en unknown
- 2010-06-25 EP EP20130158960 patent/EP2612677B1/en active Active
- 2010-06-25 EP EP10730134.3A patent/EP2340033B1/en active Active
- 2010-06-25 PT PT131589608T patent/PT2612677E/pt unknown
- 2010-06-25 PT PT107301343T patent/PT2340033E/pt unknown
- 2010-06-25 CA CA2764423A patent/CA2764423A1/en not_active Withdrawn
- 2010-06-25 CN CN201410659076.5A patent/CN104667264B/zh active Active
- 2010-06-25 WO PCT/EP2010/059069 patent/WO2010149772A1/en not_active Ceased
- 2010-06-25 DK DK13158960.8T patent/DK2612677T3/en active
- 2010-06-25 AU AU2010264636A patent/AU2010264636B2/en active Active
- 2010-06-25 KR KR1020127000115A patent/KR101775000B1/ko active Active
- 2010-06-25 DK DK10730134.3T patent/DK2340033T3/da active
- 2010-06-25 RU RU2012100397A patent/RU2533217C3/ru active Protection Beyond IP Right Term
- 2010-06-25 PL PL10730134T patent/PL2340033T3/pl unknown
- 2010-06-25 JP JP2012516763A patent/JP5669834B2/ja active Active
- 2010-06-25 PL PL13158960T patent/PL2612677T3/pl unknown
- 2010-06-25 ES ES13158960.8T patent/ES2543705T3/es active Active
- 2010-06-25 BR BRPI1014760A patent/BRPI1014760B8/pt active IP Right Grant
- 2010-06-25 CN CN201080029548.9A patent/CN102470165B/zh active Active
- 2010-06-25 ES ES10730134.3T patent/ES2440289T3/es active Active
- 2010-06-25 MX MX2011012764A patent/MX2011012764A/es active IP Right Grant
- 2010-06-28 TW TW099121012A patent/TWI459962B/zh active
2011
- 2011-11-22 IL IL216520A patent/IL216520A/en active IP Right Grant
- 2011-12-01 US US13/309,134 patent/US8324157B2/en active Active
- 2011-12-06 ZA ZA2011/08942A patent/ZA201108942B/en unknown
2012
- 2012-11-07 US US13/671,034 patent/US20130281364A1/en not_active Abandoned
2014
- 2014-03-24 US US14/223,408 patent/US20140206610A1/en not_active Abandoned
- 2014-11-04 JP JP2014223915A patent/JP6026485B2/ja active Active
2015
- 2015-03-16 US US14/658,358 patent/US20150182595A1/en not_active Abandoned
2017
- 2017-06-06 HU HUS1700027C patent/HUS1700027I1/hu unknown
- 2017-07-06 NO NO2017031C patent/NO2017031I1/no unknown

Also Published As

Publication number	Publication date
AU2010264636B2 (en)	2013-06-27
CN102470165B (zh)	2014-12-24
ES2440289T3 (es)	2014-01-28
HUS1700027I1 (hu)	2017-07-28
IL216520A (en)	2017-08-31
DK2612677T3 (en)	2015-07-27
RU2533217C2 (ru)	2014-11-20
JP5669834B2 (ja)	2015-02-18
AU2010264636A1 (en)	2012-01-12
RU2533217C3 (ru)	2020-12-21
HUE027239T2 (en)	2016-10-28
CN104667264A (zh)	2015-06-03
JP2015071608A (ja)	2015-04-16
ZA201108942B (en)	2012-08-29
JP6026485B2 (ja)	2016-11-16
US20120135920A1 (en)	2012-05-31
ES2543705T3 (es)	2015-08-21
TW201100093A (en)	2011-01-01
US8324157B2 (en)	2012-12-04
EP2340033A1 (en)	2011-07-06
US20150182595A1 (en)	2015-07-02
KR101775000B1 (ko)	2017-09-04
US20140206610A1 (en)	2014-07-24
PL2612677T3 (pl)	2015-10-30
BRPI1014760A8 (pt)	2018-01-09
RU2012100397A (ru)	2013-08-10
BRPI1014760B1 (pt)	2021-04-13
PT2612677E (pt)	2015-09-10
IL216520A0 (en)	2012-02-29
JP2012530768A (ja)	2012-12-06
WO2010149772A1 (en)	2010-12-29
CA2764423A1 (en)	2010-12-29
EP2340033B1 (en)	2013-10-09
BRPI1014760A2 (pt)	2017-07-18
MX2011012764A (es)	2012-01-20
EP2612677A1 (en)	2013-07-10
US20130281364A1 (en)	2013-10-24
TWI459962B (zh)	2014-11-11
DK2340033T3 (da)	2014-01-20
CN102470165A (zh)	2012-05-23
NO2017031I1 (no)	2017-07-06
CN104667264B (zh)	2018-09-07
PT2340033E (pt)	2014-02-04
KR20120047226A (ko)	2012-05-11
EP2612677B1 (en)	2015-05-06
BRPI1014760B8 (pt)	2021-05-25

Publication	Publication Date	Title
HUS1700027I1 (hu)	2017-07-28	Inzulint, nikotinamidot és arginint tartalmazó készítmény
IL222930A0 (en)	2012-12-31	Chlorotoxin variants, conjugates and methods for their use
EP2590653A4 (en)	2014-01-01	5-CHLORO-4-HYDROXY-1-METHYL-2-OXO-N-PHENYL-1,2-DIHYDROCHINOLINE-3-CARBOXAMIDE, SALT THEREOF AND APPLICATIONS THEREOF
EP2530079A4 (en)	2013-06-19	PHENYL-C-GLUCOSIDE DERIVATIVES, PREPARATION METHODS AND USES THEREOF
IL218490A0 (en)	2012-04-30	Substituted dihydro benzocycloalkyloxymethyl oxazolopyrimidinones, preparation and use thereof
PT2655375E (pt)	2015-03-02	Derivados de pirimidinona, sua preparação e sua utilização farmacêutica
IL215684A0 (en)	2012-01-31	Trehalulose-containing composition, its preparation and use
ZA201209595B (en)	2014-03-26	N-acetyl-dl-leucine, neuroprotective and retinoprotective medicament
IL226336A0 (en)	2013-07-31	A preparation containing insulin, nicotinamide and amino acid
IL224472A (en)	2016-12-29	Fibrin base scaffold, its use and manner of preparation
IL219888A0 (en)	2012-07-31	Pyridine-pyridinone derivatives, preparation and therapeutic use thereof
ZA201406382B (en)	2015-12-23	Levoisovalerylspiramycin i,ii,iii and preparations ,preparation methods and uses thereof
SG10201606838VA (en)	2016-09-29	Infusion preparation
ZA201206740B (en)	2013-06-26	Aildenafil citrate crystal form o,preparation method and use thereof
IL226108A0 (en)	2013-06-27	Highly efficient catalysts, their preparation and use
GB2488494B (en)	2014-12-31	Solution, use and method of preparation thereof
SI2421864T1 (sl)	2014-11-28	1-pirazolo(4,3-c)izokinolinski derivati, njihova priprava in njihova terapevtska uporaba
IL214544A0 (en)	2011-09-27	Substituted 3-benzofuranyl-indol-2-one-3-acetamidopiperazine derivatives, preparation thereof, and therapeutic use thereof
EP2621490A4 (en)	2014-04-02	PROPARGYL-TRIFLUOROMETHOXY-AMINO-BENZOTHIAZOLE DERIVATIVES, PREPARATION THEREOF AND USE THEREOF
EP2573067A4 (en)	2014-10-29	AROMATIC BUTANE-2-OL COMPOUNDS AND MANUFACTURING METHOD AND USES THEREOF
AP2012006129A0 (en)	2012-02-29	Benzamide derivatives, preparation and use thereof.
IL220859A0 (en)	2012-09-24	Alkyl-heterocycle-carbamate derivatives, their preparation and therapeutic application
GB201000148D0 (en)	2010-02-24	Article, its manufacture and use
GB0902875D0 (en)	2009-04-08	Medicaments,uses and methods
IL219495A0 (en)	2012-06-28	9-aminoacridine derivatives, their preparation and uses